Pro Vise Management Group, LLC Zoetis Inc. Transaction History

Pro Vise Management Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$81.56 - $100.67 $600,607 - $741,333	-7,364 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$79.28 - $95.27 $3,488 - $4,191	-44 Reduced 0.59%	7,364 $630,000
Q3 2018 Nov 05, 2018	BUY	$83.5 - $93.23 $4,091 - $4,568	49 Added 0.67%	7,408 $678,000
Q2 2018 Aug 13, 2018	SELL	$79.9 - $89.2 $146,696 - $163,771	-1,836 Reduced 19.97%	7,359 $627,000
Q1 2018 May 09, 2018	SELL	$71.51 - $84.69 $6,292 - $7,452	-88 Reduced 0.95%	9,195 $768,000
Q4 2017 Feb 07, 2018	BUY	$63.24 - $72.8 $69,816 - $80,371	1,104 Added 13.5%	9,283 $668,000
Q3 2017 Nov 08, 2017	BUY	$59.73 - $65.4 $488,531 - $534,906	8,179	8,179 $522,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Vise Management Group, LLC with notifications on news.